Rasmus Stenlid
0000-0002-1586-9310
Uppsala University
10 papers found
Refreshing results…
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate‐exposed human islets
Metformin Can Attenuate Beta-Cell Hypersecretion—Implications for Treatment of Children with Obesity
Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial
High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition
Adherence to Treatment Recommendations in Chronic Disease: What Is (Im)Possible? Expert Conclusions from the 30th ECOG Workshop 2021
Altered mitochondrial metabolism in peripheral blood cells from patients with inborn errors of β‐oxidation
High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
Missing publications? Search for publications with a matching author name.